TotalMarketCap

Monte Rosa Therapeutics

GLUENasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$872.756 M

$10.23 -5.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Monte Rosa Therapeutics (GLUE) has a market capitalization of $872.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$38.6M

Loss-making

Shares outstanding

85,450,119

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #46ImmaticsIMTX$930.0M
  2. #47Odyssey TherapeuticsODTX$904.9M
  3. #48Monte Rosa TherapeuticsGLUE$872.8M
  4. #49MeiraGTxMGTX$818.2M
  5. #50Prime MedicinePRME$806.2M

What if Monte Rosa Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$330,978.18

Per share 32,354× higher

Bitcoin $1.53T

$17,908.65

Per share 1,751× higher

Apple $5.02T

$58,792.44

Per share 5,747× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Monte Rosa Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.